COMPLETEDN/A

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

The aim of the present study is to quantify the dose and usage of sympathomimetics used in caesarean section.

Sponsor

Johann Wolfgang Goethe University Hospital

Enrollment

240 participants

Sites

1 locations

Start Date

October 2017

Completion

November 2017

HypotensionCesarean Section ComplicationsGranisetron HydrochlorideNo Granisetron

Enrollment & Timeline

Completed

Target N

240

participants

Sites

locations

Duration

4 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 60.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Sympathomimetics

30 minutes starting with induction of spinal anesthesia.

Type of sympathomimetics during during the operation

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Granisetron reduces the need for uterotonics but not sympathomimetics during cesarean delivery.

Raimann Florian J, Baldauf Henrica P, Louwen Frank et al.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2019

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

COMPLETEDN/A

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

The aim of the present study is to quantify the dose and usage of sympathomimetics used in caesarean section.

Sponsor

Johann Wolfgang Goethe University Hospital

Enrollment

240 participants

Sites

1 locations

Start Date

October 2017

Completion

November 2017

HypotensionCesarean Section ComplicationsGranisetron HydrochlorideNo Granisetron

Enrollment & Timeline

Completed

Target N

240

participants

Sites

locations

Duration

4 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 60.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Sympathomimetics

30 minutes starting with induction of spinal anesthesia.

Type of sympathomimetics during during the operation

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Granisetron reduces the need for uterotonics but not sympathomimetics during cesarean delivery.

Raimann Florian J, Baldauf Henrica P, Louwen Frank et al.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2019

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)